NEO NeoGenomics, Inc. - Common Stock
$16,21
Kurs · Aug 18, 2026
Fundamentaldaten per Jul 28, 2026
52W-Spanne
$6–$17
94% of range
Analystenbewertung
BUY
16 analysts
Kursziel
$20
+22% upside
P/E (TTM)
-68.3
ROE
-12.8%
Nettogewinnmarge
-14.8%
Über NeoGenomics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Mehr lesen
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
## History
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.
In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.
In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.
In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.
In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
NEO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$16.21
Marktkapitalisierung
$2.10B
P/E (TTM)
-68.3
EPS (TTM)
—
Umsatz (TTM)
$727M
Dividendenrendite
—
ROE
-12.8%
Verschuldungsgrad
0.4
52W-Spanne
$6 – $17
NEO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$727M
2016-12-31
→
2025-12-31
EPS
—
Freier Cashflow
$-22M
2017-12-31
→
2025-12-31
Margen
-14.8%
2019-12-31
→
2025-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
NEO
Peer-Median
P/E (TTM)
-68.3
32.1
P/S (TTM) (K/V (TTM))
2.9
0.8
P/B (K/B)
2.5
2.0
EV / EBITDA
-19.7
—
Price / FCF (Kurs / FCF)
-96.5
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
NEO
Peer-Median
Gross Margin (Bruttogewinnmarge)
43.2%
27.6%
Operating Margin (Betriebsgewinnmarge)
-15.9%
—
Net Profit Margin (Nettogewinnmarge)
-14.8%
0.79%
ROA
-7.2%
1.3%
ROE
-12.8%
3.9%
ROIC
-9.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
NEO
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.4
—
Current Ratio (Liquiditätsgrad)
4.3
1.3
Quick Ratio
3.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
NEO
Peer-Median
Revenue YoY (Umsatz YoY)
10.1%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
12.6%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
10.3%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
NEO
Peer-Median
NEO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
16 Analysten
- Starker Kauf 4 25,0%
- Kauf 7 43,8%
- Halten 5 31,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-14
Median
$19.00
Jetzt
$16.21
Tief
$16.00
Hoch
$35.00
Median-Ziel
$19.00
+17,2%
Mittelwert-Ziel
$19.72
+21,7%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $0.05 | $0.03 | 0.02% |
| 31. März 2026 | $0.01 | $0.01 | 0.00% |
| 31. Dezember 2025 | $0.06 | $0.04 | 0.02% |
| 30. September 2025 | $0.03 | $0.02 | 0.01% |
| 30. Juni 2025 | $0.03 | $0.02 | 0.01% |
| 31. März 2025 | $0.00 | $-0.01 | 0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | — | — | 17.9% | 3.4% | 24.8% | 20.2% |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| WGS | — | — | — | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Cost of Revenue | $413M | $370M | $347M | $322M | $297M | $259M | $212M | $149M | $138M | $134M | $56M | $46M | |
| Gross Profit | $314M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $98M | $44M | $41M | |
| R&D Expense | $37M | $31M | $27M | $30M | $22M | $8M | $8M | $3M | $4M | $5M | $4M | $3M | |
| SG&A Expense | $273M | $260M | $243M | $243M | $221M | $144M | $128M | $85M | $70M | $64M | $34M | $24M | |
| Operating Expenses | $430M | $382M | $352M | $346M | $306M | $200M | $184M | $117M | $99M | $96M | $49M | $38M | |
| Operating Income | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | $10M | $3M | $2M | $-6M | $2M | |
| Interest Expense | · | · | $7M | $8M | $8M | $7M | $4M | $6M | $6M | · | $854.0K | $985.0K | |
| Interest Income | $9M | $18M | $17M | $6M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $296.0K | $-379.0K | $644.0K | $-213.0K | $-499.0K | $8M | $-5M | $14.0K | $-12.0K | $0 | $2M | $56.0K | |
| Pretax Income | $-110M | $-81M | $-97M | $-159M | $-15M | $-14M | $4M | $4M | $-3M | $-8M | $-4M | $1M | |
| Income Tax | $-2M | $-2M | $-9M | $-15M | $-7M | $-18M | $-4M | $1M | $-2M | $-2M | $-2M | $157.0K | |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| Shares (Basic) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 108,579,000 | 100,470,000 | 85,618,000 | 79,426,000 | 77,542,000 | 60,526,000 | 53,483,000 | |
| Shares (Diluted) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 111,794,000 | 103,615,000 | 91,568,000 | 79,426,000 | 77,542,000 | 60,526,000 | 56,016,000 | |
| EBITDA | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | · | $2M | · | $-6M | · |
Bilanz 29
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | |
| Receivables | $159M | $151M | $131M | $120M | $112M | $107M | $94M | $77M | $60M | $56M | $49M | $20M | |
| Inventory | $29M | $27M | $24M | $24M | $23M | $30M | $14M | $9M | $7M | $6M | $5M | $3M | |
| Prepaid Expense | $21M | $20M | $18M | $15M | $12M | $12M | $6M | $8M | $5M | $5M | $5M | $1M | |
| Other Current Assets | $7M | $12M | $8M | $8M | $8M | $5M | $3M | $561.0K | $1M | · | · | · | |
| Current Assets | $376M | $596M | $597M | $605M | $682M | $449M | $291M | $104M | $86M | $79M | $82M | $59M | |
| PP&E (Net) | $85M | $94M | $92M | $102M | $109M | $86M | $64M | $61M | $37M | $34M | $35M | $15M | |
| PP&E (Gross) | $294M | $284M | $250M | $234M | $219M | $179M | $133M | $111M | $77M | $61M | $61M | $35M | |
| Accum. Depreciation | $209M | $190M | $158M | $132M | $110M | $93M | $69M | $50M | $41M | $27M | $27M | $20M | |
| Goodwill | $524M | $523M | $523M | $523M | $527M | $211M | $199M | $198M | $147M | $147M | $147M | $3M | |
| Intangibles | $287M | $340M | $373M | $408M | $442M | $121M | $127M | $140M | $74M | $77M | $88M | $4M | |
| Other Non-current Assets | $9M | $6M | $5M | $5M | $7M | $5M | $3M | $3M | $891.0K | $174.0K | $129.0K | $141.0K | |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Accounts Payable | $23M | $22M | $20M | $21M | $18M | $25M | $20M | $18M | $10M | $17M | $12M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $88M | $301M | $96M | $90M | $87M | $73M | $64M | $61M | $36M | $38M | $40M | $15M | |
| Capital Leases | $63M | $61M | $68M | $69M | $72M | $42M | $24M | $5M | $5M | $5M | $5M | $5M | |
| Deferred Tax | $18M | $22M | $24M | $35M | $55M | $5M | $16M | $22M | $7M | · | $16M | $821.0K | |
| Other Non-current Liabilities | $12M | $12M | $13M | $13M | $14M | $4M | $4M | $3M | $283.0K | · | · | · | |
| Total Liabilities | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $140M | $151M | $113M | $21M | |
| Long-term Debt | $342M | $541M | $538M | · | · | · | · | $102M | $97M | $98M | $55M | · | |
| Total Debt | $342M | $541M | · | · | · | $0 | · | · | $95M | · | $53M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $60.0K | |
| Retained Earnings | $-434M | $-326M | $-247M | $-159M | $-15M | $-7M | $-11M | $-19M | $-58M | $-52M | $-22M | $-19M | |
| Treasury Stock | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $-206.0K | $-2M | $-4M | $-638.0K | $10.0K | $-2M | $-579.0K | $274.0K | · | · | · | |
| Stockholders' Equity | $837M | $902M | $942M | $998M | $1.11B | $694M | $507M | $320M | $172M | $162M | $209M | $60M | |
| Liabilities + Equity | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Shares Outstanding | 128,989,152 | 128,145,333 | 127,369,142 | 126,913,992 | 124,107,500 | 112,075,474 | 104,781,236 | 94,465,440 | 80,462,574 | 78,571,158 | 75,820,307 | 60,242,818 |
Cashflow 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $26M | $20M | $16M | $16M | $16M | $7M | $5M | |
| Stock-based Comp | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7M | $6M | $5M | $3M | $641.0K | |
| Deferred Tax | $-3M | $-3M | $-10M | $-15M | $-7M | $-18M | $-4M | $2M | $-2M | $-2M | $-2M | · | |
| Amort. of Intangibles | $32M | $33M | $35M | $34M | $23M | $10M | $10M | $6M | $7M | $7M | $412.0K | $295.0K | |
| Restructuring | $0 | $7M | $11M | $5M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $5M | $7M | $-2M | $-66M | $-27M | $1M | $23M | $45M | $18M | $21M | $6M | $9M | |
| CapEx | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | |
| Investing Cash Flow | $-12M | $13M | $77M | $517.0K | $-632M | $-159M | $-20M | $-140M | $-14M | · | · | · | |
| Stock Issued | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | $9M | $3M | · | · | $34M | |
| Net Stock Activity | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-200M | $5M | $5M | $12M | $725M | $236M | $159M | $92M | $-4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | $78M | $163M | $-3M | $296.0K | $-11M | $-10M | $29M | |
| Taxes Paid | $515.0K | $207.0K | $175.0K | $180.0K | $148.0K | $246.0K | $319.0K | $-31.0K | $284.0K | $290.0K | · | · | |
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M | $-28M | $3M | · | $4M | · | $4M | · | |
| Levered FCF | · | · | $-37M | $-98M | $-94M | $-26M | $-5M | · | · | · | $4M | · |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | · | · | · | 875.1% | · | |
| Operating Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| Net Margin | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.94% | 2.0% | · | · | · | -50.7% | · | |
| Pretax Margin | -15.2% | -12.2% | -16.4% | -31.3% | -3.1% | -3.2% | 0.89% | · | · | · | -89.8% | · | |
| EBITDA Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| ROA | -7.2% | -4.7% | -5.1% | -8.0% | -0.58% | 0.49% | 1.3% | · | -0.25% | · | -1.1% | · | |
| ROE | -12.8% | -8.7% | -9.3% | -14.3% | -0.74% | 0.61% | 1.6% | · | -0.50% | · | -1.9% | · | |
| ROIC | -9.6% | -6.2% | -10.4% | -14.3% | -5.9% | 0.60% | 5.6% | · | 0.21% | · | -1.2% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 | 6.1 | 4.5 | · | 2.4 | · | 2.5 | · | |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 | 4.6 | 4.2 | · | 2.1 | · | 1.8 | · | |
| Debt / Equity | 0.4 | 0.6 | · | · | · | 0.0 | · | · | 0.5 | · | 0.3 | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | · | · | · | · | · | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -15.6 | -104.7 | -23.4 | -2.0 | 3.5 | · | · | · | -6.6 | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | · | · | · | 0.0 | · | |
| Inventory Turnover | 14.9 | 14.6 | 14.3 | 13.5 | 11.2 | 11.8 | 18.4 | · | 20.1 | · | 14.5 | · | |
| Receivables Turnover | 4.7 | 4.7 | 4.7 | 4.4 | 4.4 | 4.4 | 4.8 | · | · | · | 0.1 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 11.7% | 16.1% | 5.2% | 9.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.6% | 10.9% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Net Income TTM | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| Market Cap | $1.51B | $2.10B | $2.05B | $1.15B | $3.82B | $5.64B | $2.76B | · | $713M | · | $597M | · | |
| Enterprise Value | $1.69B | $2.27B | · | · | · | $5.41B | · | · | $795M | · | $626M | · | |
| P/E | -49.0 | -68.7 | -67.4 | -38.5 | -142.2 | -224.3 | -121.9 | -52.5 | -36.9 | -35.7 | -196.8 | 208.5 | |
| P/S | 2.1 | 3.2 | 3.5 | 2.2 | 7.9 | 12.7 | 6.8 | · | 3.0 | · | 119.3 | · | |
| P/B | 1.8 | 2.3 | 2.2 | 1.1 | 3.5 | 8.1 | 5.4 | · | 4.1 | · | 2.8 | · | |
| P / Tangible Book | 58.7 | 52.6 | 45.0 | 17.1 | 27.5 | 15.6 | · | · | · | · | · | · | |
| P / Cash Flow | 288.1 | 298.9 | -1051.4 | -17.4 | -143.1 | 3864.0 | 118.2 | · | 39.5 | · | 93.3 | · | |
| P / FCF | -69.2 | -61.7 | -66.9 | -11.8 | -42.1 | -204.1 | 827.3 | · | 164.0 | · | 142.8 | · | |
| EV / EBITDA | -14.6 | -24.7 | · | · | · | -386.8 | · | · | 342.1 | · | -111.1 | · | |
| EV / FCF | -77.6 | -66.8 | · | · | · | -195.9 | · | · | 182.9 | · | 149.9 | · | |
| EV / Revenue | 2.3 | 3.4 | · | · | · | 12.2 | · | · | 3.3 | · | 125.2 | · | |
| Earnings Yield | -2.0% | -1.5% | -1.5% | -2.6% | -0.70% | -0.45% | -0.82% | -1.9% | -2.7% | -2.8% | -0.51% | 0.48% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M | $165M | $156M | $156M | $152M | $147M | $137M | $139M | $129M | |
| Cost of Revenue | $110M | $106M | $107M | $107M | $104M | $95M | $95M | $93M | $92M | $91M | $88M | $90M | $87M | $82M | $82M | $80M | |
| Gross Profit | $92M | $81M | $83M | $80M | $77M | $73M | $77M | $75M | $72M | $65M | $68M | $62M | $60M | $55M | $57M | $49M | |
| R&D Expense | $11M | $10M | $9M | $9M | $9M | $10M | $8M | $8M | $8M | $8M | $7M | $5M | $8M | $7M | $7M | $7M | |
| SG&A Expense | $64M | $66M | $64M | $70M | $72M | $68M | $64M | $67M | $63M | $66M | $60M | $61M | $60M | $62M | $55M | $64M | |
| Operating Expenses | $102M | $99M | $97M | $107M | $125M | $101M | $96M | $96M | $94M | $96M | $86M | $87M | $90M | $90M | $83M | $88M | |
| Operating Income | $-10M | $-18M | $-13M | $-27M | $-48M | $-28M | $-18M | $-21M | $-22M | $-31M | $-19M | $-24M | $-30M | $-35M | $-26M | $-40M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $-3M | $-3M | $2M | · | $139.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | · | |
| Other Non-op | $-17.0K | $-12.0K | $84.0K | $-335.0K | $482.0K | $65.0K | $-431.0K | $317.0K | $-2.0K | $-263.0K | $124.0K | $-96.0K | $730.0K | $-114.0K | $-1.0K | $25.0K | |
| Pretax Income | $2M | $-18M | $-12M | $-26M | $-46M | $-26M | $-16M | $-18M | $-19M | $-28M | $-15M | $-21M | $-27M | $-34M | $-26M | $-40M | |
| Income Tax | $-412.0K | $-472.0K | $-3M | $740.0K | $-724.0K | $266.0K | $-804.0K | $-150.0K | $-375.0K | $-620.0K | $-960.0K | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Net Income | $2M | $-17M | $-10M | $-27M | $-45M | $-26M | $-15M | $-18M | $-19M | $-27M | $-14M | $-19M | $-24M | $-31M | $-23M | $-37M | |
| Shares (Basic) | 129,628,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| Shares (Diluted) | 130,831,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| EBITDA | $-10M | $-18M | · | $-27M | $-48M | $-28M | · | $-21M | $-22M | $-31M | · | $-24M | $-30M | $-35M | · | $-40M |
Bilanz 27
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146M | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M | $332M | · | $306M | $289M | $276M | · | $266M | |
| Receivables | $175M | $167M | $159M | $155M | $153M | $151M | $151M | $151M | $147M | $140M | · | $133M | $125M | $119M | · | $112M | |
| Inventory | $27M | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M | $20M | · | $24M | $25M | $24M | · | $24M | |
| Prepaid Expense | $24M | $24M | $21M | $22M | $23M | $23M | $20M | $18M | $17M | $19M | · | $19M | $17M | $16M | · | $17M | |
| Other Current Assets | $10M | $7M | $7M | $11M | $10M | $12M | $12M | $8M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Current Assets | $381M | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M | $574M | · | $587M | $585M | $585M | · | $603M | |
| PP&E (Net) | $81M | $84M | $85M | $85M | $85M | $90M | $94M | $93M | $92M | $88M | · | $95M | $100M | $103M | · | $107M | |
| PP&E (Gross) | · | · | $294M | · | · | · | $284M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $223M | $216M | $209M | $209M | $201M | $199M | $190M | $181M | $176M | $168M | · | $155M | $147M | $139M | · | $125M | |
| Goodwill | $524M | $524M | $524M | $524M | $524M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | · | $523M | |
| Intangibles | $271M | $279M | $287M | $294M | $302M | $331M | $340M | $348M | $356M | $365M | · | $382M | $391M | $399M | · | $417M | |
| Other Non-current Assets | $9M | $10M | $9M | $8M | $7M | $6M | $6M | $6M | $4M | $4M | · | $5M | $5M | $5M | · | $7M | |
| Total Assets | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Accounts Payable | $21M | $26M | $23M | $23M | $27M | $16M | $22M | $17M | $17M | $18M | · | $17M | $18M | $23M | · | $14M | |
| Current Liabilities | $106M | $85M | $88M | $98M | $100M | $280M | $301M | $296M | $290M | $77M | · | $93M | $95M | $87M | · | $85M | |
| Capital Leases | $65M | $61M | $63M | $64M | $67M | $60M | $61M | $62M | $63M | $65M | · | $62M | $65M | $67M | · | $70M | |
| Deferred Tax | $17M | $17M | $18M | $21M | $20M | $21M | $22M | $23M | $23M | $23M | · | $25M | $29M | $32M | · | $38M | |
| Other Non-current Liabilities | $862.0K | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | · | $13M | $13M | $13M | · | $14M | |
| Total Liabilities | $567M | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M | $717M | · | $731M | $739M | $735M | · | $743M | |
| Long-term Debt | · | · | $342M | · | · | · | $541M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-449M | $-451M | $-434M | $-424M | $-397M | $-352M | $-326M | $-310M | $-293M | $-274M | · | $-233M | $-214M | $-190M | · | $-136M | |
| Treasury Stock | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $4.0K | $4.0K | $71.0K | $29.0K | $-56.0K | $-206.0K | $-643.0K | $-1M | $-1M | · | $-2M | $-3M | $-3M | · | $-5M | |
| Stockholders' Equity | $786M | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M | $923M | $942M | $947M | $956M | $974M | $998M | $1.01B | |
| Liabilities + Equity | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Shares Outstanding | 127,917,946 | 129,653,642 | 128,145,333 | 128,885,101 | 128,681,713 | 128,356,327 | 128,145,333 | 128,061,944 | 127,851,113 | 127,434,786 | 127,369,142 | 127,261,476 | 127,144,418 | 127,200,491 | 126,913,992 | 126,562,037 |
Cashflow 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $10M | $8M | $10M | $12M | $11M | $8M | $0 | $9M | $8M | $7M | $0 | $6M | $5M | $5M | $4M | |
| Amort. of Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $8M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $1M | $2M | $3M | $5M | · | $0 | |
| Operating Cash Flow | $20M | $-8M | $1M | $9M | $20M | $-25M | $10M | $9M | $14M | $-26M | $18M | $-5M | $-2M | $-13M | $-4M | $-16M | |
| CapEx | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M | $13M | $6M | $7M | $4M | $7M | $10M | $5M | $8M | |
| Investing Cash Flow | $-8M | $-5M | $-6M | $-277.0K | $-9M | $4M | $-5M | $-4M | $7M | $15M | $17M | $21M | $15M | $24M | $-1M | $-4M | |
| Stock Issued | $2M | $-338.0K | $431.0K | $765.0K | $-1M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $93.0K | $1M | $2M | $3M | |
| Net Stock Activity | · | $-338.0K | · | · | · | $949.0K | · | · | · | $816.0K | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-12M | $-338.0K | $431.0K | $765.0K | $-202M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $64.0K | $1M | $2M | $3M | |
| Net Change in Cash | · | · | · | $9M | · | · | · | $7M | $23M | $-11M | · | $17M | $13M | $12M | · | $-18M | |
| Taxes Paid | $711.0K | $0 | $57.0K | $0 | $458.0K | $0 | $-112.0K | $143.0K | $87.0K | $89.0K | $0 | $0 | $175.0K | $0 | $25.0K | $26.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-30M | · | · | · | $-32M | · | · | · | $-23M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-33M | · | · | · | · | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6% | 43.3% | · | 42.8% | 42.6% | 43.6% | · | 44.6% | 44.1% | 41.9% | · | 41.0% | 40.8% | 40.0% | · | 38.0% | |
| Operating Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| Net Margin | 1.1% | -9.2% | · | -14.4% | -24.9% | -15.4% | · | -10.5% | -11.3% | -17.3% | · | -12.2% | -16.6% | -22.4% | · | -28.6% | |
| Pretax Margin | 0.91% | -9.4% | · | -14.1% | -25.3% | -15.3% | · | -10.6% | -11.6% | -17.7% | · | -14.1% | -18.1% | -24.6% | · | -30.8% | |
| EBITDA Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| ROA | 0.16% | -1.2% | · | -1.8% | -3.0% | -1.6% | · | -1.1% | -1.1% | -1.6% | · | -1.1% | -1.4% | -1.7% | · | -2.0% | |
| ROE | 0.27% | -2.0% | · | -3.1% | -5.1% | -2.9% | · | -1.9% | -2.0% | -2.9% | · | -1.9% | -2.4% | -3.0% | · | -3.4% | |
| ROIC | -1.0% | -2.1% | · | -3.3% | -5.5% | -3.2% | · | -2.3% | -2.4% | -3.2% | · | -2.2% | -2.9% | -3.3% | · | -3.6% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.4 | · | 3.9 | 3.9 | 2.1 | · | 2.0 | 2.0 | 7.5 | · | 6.3 | 6.2 | 6.8 | · | 7.1 | |
| Quick Ratio | 3.0 | 3.7 | · | 3.3 | 3.1 | 1.8 | · | 1.7 | 1.7 | 6.2 | · | 4.7 | 4.4 | 4.6 | · | 4.4 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.1 | · | 8.5 | 11.8 | · | · | -284.2 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 3.6 | 3.6 | · | 4.1 | 3.6 | 3.8 | · | 3.8 | 3.8 | 4.1 | · | 3.7 | 3.7 | 3.4 | · | 3.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 |
Bewertung (TTM) 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $757M | $724M | · | $705M | $682M | $657M | · | $641M | $620M | $592M | · | $565M | $538M | $508M | · | $492M | |
| Net Income TTM | $-87M | $-115M | · | $-116M | $-107M | $-89M | · | $-82M | $-89M | $-101M | · | $-110M | $-127M | $-152M | · | $-142M | |
| Market Cap | $1.87B | $962M | · | $995M | $941M | $1.22B | · | $1.89B | $1.77B | $2.00B | · | $1.57B | $2.04B | $2.21B | · | $1.09B | |
| Enterprise Value | $2.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -60.8 | -30.9 | · | -32.2 | -30.5 | -39.5 | · | -61.5 | -57.8 | -65.5 | · | -51.2 | -67.0 | -72.5 | · | -35.9 | |
| P/S | 2.5 | 1.3 | · | 1.4 | 1.4 | 1.9 | · | 2.9 | 2.9 | 3.4 | · | 2.8 | 3.8 | 4.4 | · | 2.2 | |
| P/B | 2.4 | 1.2 | · | 1.2 | 1.1 | 1.4 | · | 2.1 | 1.9 | 2.2 | · | 1.7 | 2.1 | 2.3 | · | 1.1 | |
| P / Tangible Book | · | 37.2 | · | 50.3 | 33.5 | 35.6 | · | 50.5 | 48.3 | 55.8 | · | 36.6 | 47.8 | 42.4 | · | 14.9 | |
| P / Cash Flow | · | -118.2 | · | · | · | -48.1 | · | · | · | -77.3 | · | · | · | -174.5 | · | · | |
| P / FCF | · | -73.2 | · | · | · | -40.8 | · | · | · | -63.6 | · | · | · | -97.9 | · | · | |
| EV / EBITDA | -214.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.6% | -3.2% | · | -3.1% | -3.3% | -2.5% | · | -1.6% | -1.7% | -1.5% | · | -1.9% | -1.5% | -1.4% | · | -2.8% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $727M | $661M | $592M | $510M | $484M |
| Bruttogewinnmarge % | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% |
| Betriebsgewinnmarge % | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% |
| Nettoergebnis | $-108M | $-79M | $-88M | $-144M | $-8M |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.4 | 0.6 | — | — | — |
| Liquiditätsgrad | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-22M | $-34M | $-31M | $-97M | $-91M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 299 Einreicher · $1.8B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 64 (+22 vs. Vorquartal) | 38 (+1 vs. Vorquartal) | 93 (+20 vs. Vorquartal) | 59 (-26 vs. Vorquartal) | +33.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| First Light Asset Management, LLC | $179.158.241 | 12.279.523 | 9,76% | Aktien |
| VANGUARD GROUP INC | $150.953.759 | 12.836.204 | 8,22% | Aktien |
| FIRST TRUST ADVISORS LP | $147.552.477 | 10.113.261 | 8,04% | Aktien |
| Greenhouse Funds LLLP | $125.097.724 | 8.574.210 | 6,82% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.615.272 | 8.061.362 | 6,41% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.082.418 | 5.763.017 | 4,58% | Aktien |
| STATE STREET CORP | $78.257.609 | 5.363.784 | 4,26% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $73.501.000 | 5.037.787 | 4,00% | Aktien |
| BRAIDWELL LP | $71.756.567 | 4.918.202 | 3,91% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $61.886.083 | 4.342.883 | 3,37% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50.558.727 | 3.465.300 | 2,75% | Kaufoption |
| MILLENNIUM MANAGEMENT LLC | $44.930.518 | 3.079.542 | 2,45% | Aktien |
| TORONTO DOMINION BANK | $43.770.000 | 3.000.000 | 2,38% | Kaufoption |
| GEODE CAPITAL MANAGEMENT, LLC | $42.933.596 | 2.942.009 | 2,34% | Aktien |
| Driehaus Capital Management LLC | $36.604.049 | 2.508.845 | 1,99% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $34.896.129 | 2.391.784 | 1,90% | Aktien |
| AMERICAN CAPITAL MANAGEMENT INC | $32.648.145 | 2.237.707 | 1,78% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $32.593.724 | 2.233.977 | 1,78% | Aktien |
| UBS Group AG | $32.581.659 | 2.233.150 | 1,78% | Kaufoption |
| LOOMIS SAYLES & CO L P | $30.838.504 | 2.113.674 | 1,68% | Aktien |
| Aberdeen Group plc | $28.180.950 | 1.931.525 | 1,54% | Aktien |
| D. E. Shaw & Co., Inc. | $27.938.858 | 1.914.932 | 1,52% | Aktien |
| GLENMEDE TRUST CO NA | $20.985.657 | 1.438.359 | 1,14% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17.689.018 | 1.212.407 | 0,96% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $15.850.518 | 1.086.396 | 0,86% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $12.685.640 | 869.475 | 0,69% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $11.918.848 | 816.919 | 0,65% | Aktien |
| SAMLYN CAPITAL, LLC | $11.869.359 | 813.527 | 0,65% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $11.707.337 | 802.422 | 0,64% | Aktien |
| Glenmede Investment Management, LP | $11.359.995 | 1.471.502 | 0,62% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $9.141.555 | 626.563 | 0,50% | Aktien |
| HighMark Wealth Management LLC | $8.936.871 | 612.534 | 0,49% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $7.841.935 | 537.487 | 0,43% | Aktien |
| Public Sector Pension Investment Board | $6.526.545 | 447.330 | 0,36% | Aktien |
| Trexquant Investment LP | $6.358.074 | 435.783 | 0,35% | Aktien |
| GOLDMAN SACHS GROUP INC | $5.559.884 | 381.075 | 0,30% | Aktien |
| Bank of New York Mellon Corp | $5.554.938 | 380.736 | 0,30% | Aktien |
| Granite Investment Partners, LLC | $5.181.507 | 355.141 | 0,28% | Aktien |
| RHUMBLINE ADVISERS | $4.624.054 | 316.935 | 0,25% | Aktien |
| AMERIPRISE FINANCIAL INC | $4.623.822 | 316.917 | 0,25% | Aktien |
| Weiss Asset Management LP | $4.171.558 | 285.919 | 0,23% | Aktien |
| Swiss National Bank | $3.800.695 | 260.500 | 0,21% | Aktien |
| SUSQUEHANNA ADVISORS GROUP, INC. | $3.770.056 | 258.400 | 0,21% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.680.109 | 252.235 | 0,20% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.455.481 | 236.839 | 0,19% | Aktien |
| FMR LLC | $3.409.026 | 233.655 | 0,19% | Aktien |
| Squarepoint Ops LLC | $3.239.505 | 222.036 | 0,18% | Aktien |
| ExodusPoint Capital Management, LP | $3.128.811 | 214.449 | 0,17% | Aktien |
| Legal & General Group Plc | $2.907.700 | 199.294 | 0,16% | Aktien |
| PEAK6 LLC | $2.651.003 | 181.700 | 0,14% | Kaufoption |
| FEDERATED HERMES, INC. | $2.510.064 | 172.040 | 0,14% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.221.357 | 152.252 | 0,12% | Aktien |
| WHITE PINE CAPITAL LLC | $2.167.184 | 148.539 | 0,12% | Aktien |
| PRUDENTIAL FINANCIAL INC | $2.017.870 | 138.305 | 0,11% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $1.987.158 | 136.200 | 0,11% | Aktien |
| BlackRock, Inc. | $1.962.691 | 134.523 | 0,11% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.943.067 | 133.178 | 0,11% | Aktien |
| STEELHEAD PARTNERS LLC | $1.885.028 | 129.200 | 0,10% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.787.859 | 122.540 | 0,10% | Aktien |
| Greenhouse Funds LLLP | $1.689.522 | 115.800 | 0,09% | Kaufoption |
| PERKINS CAPITAL MANAGEMENT INC | $1.605.483 | 110.040 | 0,09% | Aktien |
| GABELLI FUNDS LLC | $1.597.605 | 109.500 | 0,09% | Aktien |
| ARISTEIA CAPITAL, L.L.C. | $1.571.343 | 107.700 | 0,09% | Aktien |
| IEQ CAPITAL, LLC | $1.524.305 | 104.476 | 0,08% | Aktien |
| Verition Fund Management LLC | $1.477.019 | 101.235 | 0,08% | Aktien |
| GAMCO INVESTORS, INC. ET AL | $1.459.000 | 100.000 | 0,08% | Aktien |
| Fernwood Investment Management, LLC | $1.453.536 | 88.200 | 0,08% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.440.244 | 194.103 | 0,08% | Aktien |
| XTX Topco Ltd | $1.413.552 | 96.885 | 0,08% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.403.354 | 96.186 | 0,08% | Aktien |
| CITADEL ADVISORS LLC | $1.324.772 | 90.800 | 0,07% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.279.178 | 87.675 | 0,07% | Aktien |
| Curi Capital, LLC | $1.256.666 | 86.132 | 0,07% | Aktien |
| MFG WEALTH MANAGEMENT, INC. | $1.217.711 | 83.462 | 0,07% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.189.723 | 160.340 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $1.120.293 | 76.785 | 0,06% | Aktien |
| Mariner, LLC | $1.117.405 | 76.587 | 0,06% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1.039.421 | 71.242 | 0,06% | Aktien |
| TWO SIGMA ADVISERS, LP | $983.136 | 83.600 | 0,05% | Aktien |
| Russell Investments Group, Ltd. | $967.068 | 66.283 | 0,05% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $962.429 | 65.965 | 0,05% | Aktien |
| MORGAN STANLEY | $954.638 | 65.431 | 0,05% | Aktien |
| Quantinno Capital Management LP | $945.359 | 64.795 | 0,05% | Aktien |
| Illinois Municipal Retirement Fund | $932.520 | 63.915 | 0,05% | Aktien |
| WINTON GROUP Ltd | $924.700 | 63.379 | 0,05% | Aktien |
| Quantbot Technologies LP | $922.540 | 63.231 | 0,05% | Aktien |
| CHOREO, LLC | $889.115 | 60.940 | 0,05% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $884.373 | 60.615 | 0,05% | Aktien |
| MOODY NATIONAL BANK TRUST DIVISION | $860.445 | 58.975 | 0,05% | Aktien |
| Louisiana State Employees Retirement System | $833.089 | 57.100 | 0,05% | Aktien |
| SIMPLEX TRADING, LLC | $796.453 | 54.589 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $786.401 | 53.900 | 0,04% | Kaufoption |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $786.109 | 53.880 | 0,04% | Aktien |
| Teton Advisors, LLC | $774.729 | 53.100 | 0,04% | Aktien |
| Invesco Ltd. | $766.515 | 52.537 | 0,04% | Aktien |
| COMMERCE BANK | $764.632 | 52.408 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $741.070 | 50.793 | 0,04% | Aktien |
| BARD ASSOCIATES INC | $683.761 | 46.865 | 0,04% | Aktien |
| Alamea Verwaltungs GmbH | $683.702 | 46.861 | 0,04% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $674.467 | 46.228 | 0,04% | Aktien |
Unternehmensinsider 52 Insider · 30 Führungskräfte · 23 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer | 1. Juni 2025 M | 20.166 | 0 | 0 | $0 |
| Christopher M Smith | Chief Executive Officer | 23. Februar 2025 M | 641.585 | 0 | 0 | $0 |
| Mark Mallon | Chief Executive Officer | 1. März 2022 A | 368.051 | 0 | 0 | $0 |
| Jeffrey Scott Sherman | Chief Financial Officer | 11. Mai 2025 M | 168.332 | 0 | 0 | $0 |
| William Bonello | Chief Financial Officer | 28. April 2022 M | 191.548 | 0 | 0 | $0 |
| Sharon Virag | Chief Financial Officer | 1. März 2019 A | 10.944 | 0 | 0 | $0 |
| Vishal Sikri | President Advanced Diagnostics | 23. Februar 2024 A | 148.455 | 0 | 0 | $0 |
| David Sholehvar | President, Clinical Services | 1. August 2022 A | 43.216 | 0 | 0 | $0 |
| George Cardoza | President & COO, Lab Ops | 2. März 2022 F | 244.157 | 0 | 0 | $0 |
| Gina M Wallar | President, Pharma Services | 1. März 2022 A | 33.443 | 0 | 0 | $0 |
| Clive Morris | President of Inivata | 30. Dezember 2021 A | 41.280 | 0 | 0 | $0 |
| Robert J. Shovlin | President, Clinical Services | 25. Mai 2021 M | 150.101 | 0 | 0 | $0 |
| Warren Stone | Pres & Chief Operating Officer | 11. Mai 2025 M | 108.280 | 0 | 0 | $0 |
| Alicia C Olivo | EVP, GC & Business Development | 1. September 2025 F | 47.940 | 0 | 0 | $0 |
| Melody Harris | Chf Ops Off, Pres, Informatics | 23. Februar 2025 M | 109.755 | 0 | 0 | $0 |
| Shashikant Kulkarni | Chief Scientific Officer | 1. April 2023 F | 82.673 | 0 | 0 | $0 |
| Cynthia J Dieter | Chief Accounting Officer | 2. März 2023 F | 29.765 | 0 | 0 | $0 |
| Douglas Matthew Brown | Chief Strategy Officer | 1. April 2022 A | 158.684 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Legal Officer | 1. März 2022 A | 147.396 | 0 | 0 | $0 |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | 11. Januar 2022 M | 49.361 | 0 | 0 | $0 |
| Jennifer Balliet | VP and Chief Culture Officer | 30. Dezember 2021 A | 48.615 | 0 | 0 | $0 |
| Lawrence Martin Weiss | Chief Medical Officer | 22. April 2021 M | 130.847 | 0 | 0 | $0 |
| Denise E Pedulla | General Counsel | 2. März 2021 A | 60.643 | 0 | 0 | $0 |
| Steven G. Brodie | VP - Pharma Operations | 22. Oktober 2018 M | 45.953 | 0 | 0 | $0 |
| Steven A Ross | CIO | 10. Mai 2018 X | 4.500 | 0 | 0 | $0 |
| Maher Albitar | Chief Medical Officer | 25. Mai 2017 A | 60.692 | 0 | 0 | $0 |
| Mark Alan Machulcz | Vice President of Operations | 28. Januar 2016 A | — | 0 | 0 | $0 |
| Robert H. Horel | Vice President GM PathLogic | 29. Dezember 2015 X | 51.218 | 0 | 0 | $0 |
| Robert P Gasparini | Chief Science Officer | 22. Mai 2014 X | 8.439 | 0 | 0 | $0 |
| Mark W Smits | Chief Commercial Officer | 18. Mai 2011 M | 0 | 0 | 0 | $0 |
| Carolyn S Starrett | Direktor | 23. Juni 2026 A | — | 0 | 0 | $0 |
| Lynn A. Tetrault | Direktor | 15. Juni 2026 S | 86.115 | 0 | 2 | $-118.824 |
| Marjorie C Green | Direktor | 1. Juni 2026 A | 22.964 | 0 | 0 | $0 |
| Neil Gunn | Direktor | 1. Juni 2026 A | 51.177 | 0 | 0 | $0 |
| Michael Aaron Kelly | Direktor | 1. Juni 2026 A | 67.086 | 0 | 0 | $0 |
| David Brian Perez | Direktor | 1. Juni 2026 A | 56.967 | 0 | 0 | $0 |
| John P. Kenny | Direktor | 1. Juni 2026 A | 5.893 | 0 | 0 | $0 |
| Stephen M Kanovsky | Direktor | 1. Juni 2026 A | 75.421 | 0 | 0 | $0 |
| Felicia Williams | Direktor | 1. Juni 2026 A | 30.237 | 0 | 0 | $0 |
| Elizabeth Floegel | Direktor | 1. Juni 2025 A | 23.590 | 0 | 0 | $0 |
| Alison L. Hannah | Direktor | 1. Juni 2025 M | 131.023 | 0 | 0 | $0 |
| Bruce K Crowther | Direktor | 10. August 2023 A | 65.120 | 0 | 0 | $0 |
| Rachel A Stahler | Direktor | 10. Juni 2022 A | 21.335 | 0 | 0 | $0 |
| David Daly | Direktor | 10. Juni 2022 A | 17.179 | 0 | 0 | $0 |
| Kevin C Johnson | Direktor | 22. Dezember 2021 M | 37.398 | 0 | 0 | $0 |
| Douglas M Van Oort | Direktor | 1. August 2021 F | 2.468.797 | 0 | 0 | $0 |
| Steven C Jones | Direktor | 7. Januar 2021 M | 90.218 | 0 | 0 | $0 |
| Raymond R Hipp | Direktor | 16. November 2020 S | 66.800 | 0 | 0 | $0 |
| William J Robison | Direktor | 25. Mai 2017 A | 183.348 | 0 | 0 | $0 |
| Michael T Dent | Direktor | 4. Dezember 2014 S | 1.384.150 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| IRS IDENTIFICATION NO. NeoGenomics, Inc. | 12. April 2007 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 62 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,12% | 167.212 SH | 8. August 2026 | Täglich |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,09% | 113.008 SH | 8. August 2026 | Täglich |
| LFSC · RBB Fund, Inc. | 0,43% | 43.071 NS | 31. Mai 2026 | N-PORT |
| IHF · iShares Trust | 0,31% | 243.554 SH | 8. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,14% | 154.408 NS | 30. April 2026 | N-PORT |
| IJT · iShares Trust | 0,13% | 700.692 SH | 8. August 2026 | Täglich |
| XJR · iShares Trust | 0,13% | 15.435 SH | 8. August 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,12% | 19.262 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 211.878 SH | 8. August 2026 | Täglich |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,12% | 89.895 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,12% | 1.117.630 SH | 8. August 2026 | Täglich |
| IJR · iShares Trust | 0,11% | 7.947.524 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 104.297 SH | 8. August 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,10% | 455.144 SH | 8. August 2026 | Täglich |
| NUSC · Nushares ETF Trust | 0,10% | 135.666 NS | 30. April 2026 | N-PORT |
| IJS · iShares Trust | 0,09% | 489.210 SH | 8. August 2026 | Täglich |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,09% | 116.046 SH | 8. August 2026 | Täglich |
| ESML · iShares Trust | 0,09% | 158.897 SH | 8. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,07% | 93.313 NS | 30. April 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,07% | 13.856 NS | 31. Mai 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 85.056 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,06% | 3.340.583 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,06% | 40.428 SH | 8. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 49.165 NS | 30. April 2026 | N-PORT |
| SAA · ProShares Trust | 0,06% | 1.546 NS | 31. Mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 757.699 SH | 8. August 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 33.295 NS | 30. April 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 1.728.845 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 106.278 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,04% | 55.874 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 6.071 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 5.811 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 388.986 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 628.556 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 425.333 NS | 30. April 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,03% | 14.399 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.492.431 SH | 8. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,02% | 2.990.594 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,02% | 4.748 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 60.531 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 7.690 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,02% | 45.201 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 4.804 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 5.288 NS | 30. April 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 113.167 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12.627 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 5.219 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 339.840 NS | 30. April 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 15.340 NS | 30. April 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 121 NS | 31. Mai 2026 | N-PORT |